For example, miR-9 that targets several proteins associated with AD pathogenesis (e.g., BACE1, PSEN1, SIRT1, and CAMKK2) is downregulated in human AD brain samples, as well as in mouse and neuronal cell culture models. This evidence concerns the gene CAMKK2 and Alzheimer disease.